CC
Christine Mikail Cvijic
President and CFODirector

Christine Mikail Cvijic insider trades: Neurogene (NGNE) stock buys and sales

President and CFO, Neurogene Last trade Jul 7, 2026 22 Form 4 filings
$845K
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2024
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christine reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 7, 2026NGNE↓ Sell$173K
Jul 2, 2026NGNE↓ Sell$167K
May 6, 2026NGNE↓ Sell$300K
Mar 13, 2026NGNE↓ Sell$84K
Feb 27, 2026NGNE↓ Sell$121K
Mar 13, 2025NGNE↓ Sell$76K
Nov 22, 2024NGNE↑ Buy$491K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NGNE insiders

Open-market trades in the last 12 months

About Christine Mikail Cvijic's insider trades

Christine Mikail Cvijic is President and CFO at Neurogene (NGNE). Since Nov 22, 2024, Christine has reported 1 open-market purchase worth $491K and 6 sales worth $921K on SEC Form 4. In the last 12 months: 5 sales ($845K).

Their filings also include grants and awards (10 filings), shares withheld for taxes (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NGNE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.